Implications of infiltrating immune cells within bone marrow of patients with diffuse large B-cell lymphoma

Impact of Concordant and Discordant Bone Marrow Involvement on Outcome in Diffuse Large B-Cell Lymphoma Treated With R-CHOP

Laurie H. Sehn, David W. Scott, Mukesh Chhanabhai et al. · Journal of Clinical Oncology · 2011 · 232 citations · Full text

Medicine, Hematology, Oncology +14

Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.

Maureen G. Conlan, M. Bast, Jamés O. Armitage et al. · Journal of Clinical Oncology · 1990 · 186 citations

Medicine, Hematology, Pathology +16

The split nature of tumor-infiltrating leukocytes

Telma Lança, Bruno Silva‐Santos · OncoImmunology · 2012 · 148 citations · Full text

Life Sciences, Immunology, Oncology +16

Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the International Prognostic Index

Randy Chung, Raymond Lai, Peter Wei et al. · Blood · 2007 · 143 citations · Full text

Medicine, Hematology, Oncology +15

An increase of M2 macrophages predicts poor prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone

Soo Jeong Nam, Heounjeong Go, Jin Ho Paik et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2014 · 121 citations

Life Sciences, Immunology, Oncology +16